You just read:

Astellas Announces FDA Fast Track Designation for ASP0892, DNA Vaccine for Mitigation of Severe Hypersensitivity Reactions Due to Peanut Allergy

News provided by

Astellas Pharma Inc.

20 Dec, 2016, 08:00 ET